News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Essen BioScience, Inc. and Nycomed Announce Ion Channel Drug Discovery Collaboration



6/21/2010 6:46:23 AM

ANN ARBOR, Mich. & ZURICH--(BUSINESS WIRE)--Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services – and Nycomed – a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES